eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Actavis UK Ltd

Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 30/09/2010
SPC Ascorbic Acid Tablets BP 500mg


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

ASCORBIC ACID TABLETS BP 500mg


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains 500mg ascorbic acid.


Go to top of the page
3. PHARMACEUTICAL FORM

White uncoated tablets.

White, circular, flat bevelled-edge uncoated tablets impressed “C” and the identifying letters “AN” on one face; or, as an alternative, plain tablets devoid of surface markings.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

1) Ascorbic acid is a synthetic vitamin C and is specific in the treatment of scurvy.


Go to top of the page
4.2 Posology and method of administration

Tablets should be chewed before swallowing.

Adults including elderly: 500mg-1g two or three times daily.

Children over 12 years: 500mg two or three times daily.

Children 6-12 years: 500mg twice a day.

For oral administration.


Go to top of the page
4.3 Contraindications

Hyperoxaluria.


Go to top of the page
4.4 Special warnings and precautions for use

Increased intake of ascorbic acid over a prolonged period may result in an increase in renal clearance and deficiency may result if it is withdrawn too rapidly.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Concomitant administration of aluminium-containing antacids may increase urinary aluminium elimination. Concurrent administration of antacids and ascorbic acid is not recommended, especially in patients with renal insufficiency.

Concomitant administration of aspirin and ascorbic acid may interfere with absorption of ascorbic acid. Renal excretion of salicylate is not affected and does not lead to reduced anti-inflammatory effects of aspirin.

Concurrent administration of ascorbic acid with desferrioxamine enhances urinary iron excretion. Cases of cardiomyopathy and congestive heart failure have been reported in patients with idiopathic haemochromatosis and thalassaemias receiving desferrioxamine who were subsequently given ascorbic acid. Ascorbic acid should be used with caution in these patients and cardiac function monitored.

Ascorbic acid may interfere with biochemical determinations of creatinine, uric acid and glucose in samples of blood and urine.


Go to top of the page
4.6 Pregnancy and lactation

Ascorbic acid in doses greater than 1g should not be administered during pregnancy as the effect of large doses on the foetus is not known.

No problems are anticipated with the administration of ascorbic acid tablets during lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Nausea, vomiting and stomach cramps.

Flushing or redness of skin, headache, mild increase in urination with doses greater than 600mg per day.

Large doses of ascorbic acid (greater than 1g per day) may cause diarrhoea.


Go to top of the page
4.9 Overdose

Ascorbic acid may cause acidosis or haemolytic anaemia in certain individuals with a deficiency of glucose 6-phosphate dyhydrogenase. Renal failure can occur with massive ascorbic acid overdosage.

Gastric lavage may be given if ingestion is recent otherwise general supportive measures should be employed as required.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Ascorbic Acid is a synthetic vitamin C.


Go to top of the page
5.2 Pharmacokinetic properties

Ascorbic acid is readily absorbed from the gastrointestinal tract and is widely distributed in the body tissues. Ascorbic acid in excess of the body's needs is rapidly eliminated in the urine.

The most established function of vitamin C in the body is the control of the formation of colloidal intercellular substances. Deficiency of vitamin C leads to scurvy and in the absence of this water-soluble vitamin, a typical nutritional anaemia develops; the vitamin acts directly on the blood-forming centres and is essential for the maturation of the red blood cells.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Also contains: stearic acid, E223, E460.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Shelf-life

Three years from the date of manufacture.

Shelf-life after dilution/reconstitution

Not applicable.

Shelf-life after first opening

Not applicable.


Go to top of the page
6.4 Special precautions for storage

Store in a cool dry place. Protect from light. Avoid contact with metal.


Go to top of the page
6.5 Nature and contents of container

The product containers are J & J standard securitainers or Wragby snap-secure containers with jayfilla or polyfoam wad headspace filler and snap-on lids; in case any supply difficulties should arise the alternative is amber glass containers with screw caps with polyfoam wad or cotton wool.

Pack sizes: 7s, 10s, 14s, 20s, 21s, 28s, 30s, 56s, 60s, 84s, 90s, 100s, 112s, 500s, 1000s

Polyethylene container with a polypropylene lid.

Pack size: 28

Product may also be supplied in bulk packs, for reassembly purposes only, in polybags contained in tins, skillets or polybuckets filled with suitable cushioning material.

Maximum size of bulk packs: 25,000.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable


Go to top of the page
Administrative Data

Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Name or style and permanent address of registered place of business of the holder of the Marketing Authorisation:

Actavis UK Limited

(Trading style: Actavis)

Whiddon Valley

BARNSTAPLE

N Devon EX32 8NS


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0142/6435 R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

11.7.86

Renewed: 28.10.91; 14.3.02


Go to top of the page
10. DATE OF REVISION OF THE TEXT

02/07/09



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/23775/SPC/


Active Ingredients/Generics

 
   ascorbic acid